Charter Oak Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Sell
1,095
-2
-0.2% -$2.03K 0.08% 83
2025
Q4
$1.18M Sell
1,097
-9
-0.8% -$8.61K 0.09% 76
2025
Q3
$844K Sell
1,106
-193
-15% -$144K 0.07% 94
2025
Q2
$1.01M Buy
1,299
+202
+18% +$157K 0.09% 74
2025
Q1
$906K Buy
1,097
+58
+6% +$48.3K 0.08% 79
2024
Q4
$802K Sell
1,039
-22
-2% -$18.2K 0.07% 82
2024
Q3
$940K Buy
1,061
+24
+2% +$21.6K 0.09% 78
2024
Q2
$938K Sell
1,037
-3
-0.3% -$2.4K 0.1% 71
2024
Q1
$809K Buy
1,040
+4
+0.4% +$2.85K 0.09% 78
2023
Q4
$604K Sell
1,036
-10
-1% -$5.84K 0.07% 88
2023
Q3
$562K Sell
1,046
-8
-0.8% -$4.12K 0.07% 92
2023
Q2
$494K Buy
1,054
+74
+8% +$31K 0.06% 106
2023
Q1
$337K Buy
980
+8
+0.8% +$2.7K 0.05% 131
2022
Q4
$356K Buy
972
+101
+12% +$35.8K 0.05% 126
2022
Q3
$282K Hold
871
0.05% 134
2022
Q2
$282K Hold
871
0.04% 148
2022
Q1
$249K Buy
871
+1
+0.1% +$257 0.03% 164
2021
Q4
$240K Hold
870
0.03% 167
2021
Q3
$201K Buy
870
+1
+0.1% +$247 0.03% 173
2021
Q2
$199K Buy
869
+100
+13% +$20.1K 0.03% 171
2021
Q1
$144K Buy
769
+1
+0.1% +$196 0.02% 194
2020
Q4
$130K Buy
+768
New +$115K 0.02% 193

Other funds holding LLY

Charter Oak Capital Management's LLY Position: Q1 2026 in Review

Charter Oak Capital Management reduced its Eli Lilly (LLY) stake by 0.18% in Q1 2026, selling an estimated $2.03K and leaving 1,095 shares worth $1.01M. The position accounts for 0.08% of the portfolio, ranked #83.

Charter Oak Capital Management first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.18M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Charter Oak Capital Management held 1,095 shares of Eli Lilly worth $1.01M as of Q1 2026.
  • Charter Oak Capital Management sold 2 Eli Lilly shares in Q1 2026, an estimated $2.03K.
  • Eli Lilly made up 0.08% of Charter Oak Capital Management's portfolio in Q1 2026, its #83 holding.
  • Charter Oak Capital Management first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
  • Charter Oak Capital Management's Eli Lilly position peaked at $1.18M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Charter Oak Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.